BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 22419350)

  • 1. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.
    Maniar RN; Kumar G; Singhi T; Nayak RM; Maniar PR
    Clin Orthop Relat Res; 2012 Sep; 470(9):2605-12. PubMed ID: 22419350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antifibrinolytic and anti-inflammatory effects of multiple doses of oral tranexamic acid in total knee arthroplasty patients: a randomized controlled trial.
    Wang D; Luo ZY; Yu ZP; Liu LX; Chen C; Meng WK; Yu QP; Pei FX; Zhou ZK; Zeng WN
    J Thromb Haemost; 2018 Dec; 16(12):2442-2453. PubMed ID: 30430724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there an optimal timing of administration of single-dose intravenous tranexamic acid in bilateral total knee arthroplasty? A comparison between preoperative and intraoperative dose.
    Balachandar G; Abuzakuk T
    J Orthop Surg (Hong Kong); 2019; 27(3):2309499019880915. PubMed ID: 31635527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Charoencholvanich K; Siriwattanasakul P
    Clin Orthop Relat Res; 2011 Oct; 469(10):2874-80. PubMed ID: 21512813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing effectivity of tranexamic acid in bilateral knee arthroplasty - A prospective randomized controlled study.
    Maniar RN; Singhi T; Patil A; Kumar G; Maniar P; Singh J
    Knee; 2017 Jan; 24(1):100-106. PubMed ID: 27889320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of five treatment regimens on blood loss and blood transfusion in total knee arthroplasty: a preliminary study in China
.
    Hu KZ; Sun HY; Sui C
    Int J Clin Pharmacol Ther; 2017 May; 55(5):433-441. PubMed ID: 28139973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Boluses of Intravenous Tranexamic Acid to Reduce Hidden Blood Loss After Primary Total Knee Arthroplasty Without Tourniquet: A Randomized Clinical Trial.
    Xie J; Ma J; Yao H; Yue C; Pei F
    J Arthroplasty; 2016 Nov; 31(11):2458-2464. PubMed ID: 27262419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical tranexamic acid in cemented primary total knee arthroplasty without tourniquet: a prospective randomized study.
    Morales Santias M; Mas Martinez J; Sanz-Reig J; Martínez Gimenez E; Verdu Román C; Bustamante Suarez de Puga D
    Eur J Orthop Surg Traumatol; 2020 Aug; 30(6):1003-1008. PubMed ID: 32185573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between intravenous and intra-articular regimens of tranexamic acid in reducing blood loss during total knee arthroplasty.
    Soni A; Saini R; Gulati A; Paul R; Bhatty S; Rajoli SR
    J Arthroplasty; 2014 Aug; 29(8):1525-7. PubMed ID: 24814890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Efficacy Comparison of Tranexamic Acid for Reducing Blood Loss in Total Knee Arthroplasty at Different Dosage Time.
    Sun Q; Yu X; Nie X; Gong J; Cai M
    J Arthroplasty; 2017 Jan; 32(1):33-36. PubMed ID: 27449714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical vs Intravenous Tranexamic Acid in Reducing Blood Loss After Bilateral Total Knee Arthroplasty: A Prospective Study.
    Aggarwal AK; Singh N; Sudesh P
    J Arthroplasty; 2016 Jul; 31(7):1442-8. PubMed ID: 26947543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2019 Mark Coventry Award: A multicentre randomized clinical trial of tranexamic acid in revision total knee arthroplasty: does the dosing regimen matter?
    Fillingham YA; Darrith B; Calkins TE; Abdel MP; Malkani AL; Schwarzkopf R; Padgett DE; Culvern C; Sershon RA; Bini S; Della Valle CJ;
    Bone Joint J; 2019 Jul; 101-B(7_Supple_C):10-16. PubMed ID: 31256650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous vs Topical Tranexamic Acid in Total Knee Arthroplasty Without Tourniquet Application: A Randomized Controlled Study.
    Tzatzairis TK; Drosos GI; Kotsios SE; Ververidis AN; Vogiatzaki TD; Kazakos KI
    J Arthroplasty; 2016 Nov; 31(11):2465-2470. PubMed ID: 27267228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-conserving efficacy of multiple doses of oral tranexamic acid associated with an enhanced-recovery programme in primary total knee arthroplasty: a randomized controlled trial.
    Wang D; Wang HY; Luo ZY; Meng WK; Pei FX; Li Q; Zhou ZK; Zeng WN
    Bone Joint J; 2018 Aug; 100-B(8):1025-1032. PubMed ID: 30062946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous tranexamic acid only versus combined intravenous and intra-articular tranexamic acid for perioperative blood loss in patients undergoing total knee arthroplasty.
    Iseki T; Tsukada S; Wakui M; Yoshiya S
    Eur J Orthop Surg Traumatol; 2018 Oct; 28(7):1397-1402. PubMed ID: 29693237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical co-delivery of platelet rich fibrin and tranexamic acid does not decrease blood loss in primary total knee arthroplasty compared to the standard of care: a prospective, randomized, controlled trial.
    Tandogan RN; Polat M; Beyzadeoglu T; Karabulut E; Yildirim K; Kayaalp A
    Knee Surg Sports Traumatol Arthrosc; 2021 Feb; 29(2):519-528. PubMed ID: 32170355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranexamic acid in primary total knee arthroplasty without tourniquet: a randomized, controlled trial of oral versus intravenous versus topical administration.
    Wang D; Wang HY; Cao C; Li LL; Meng WK; Pei FX; Li DH; Zhou ZK; Zeng WN
    Sci Rep; 2018 Sep; 8(1):13579. PubMed ID: 30206267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study.
    Patel JN; Spanyer JM; Smith LS; Huang J; Yakkanti MR; Malkani AL
    J Arthroplasty; 2014 Aug; 29(8):1528-31. PubMed ID: 24768543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraarticular use of tranexamic acid reduces blood loss and transfusion rate after primary total knee arthroplasty.
    Tille E; Mysliwietz J; Beyer F; Postler A; Lützner J
    BMC Musculoskelet Disord; 2019 Jul; 20(1):341. PubMed ID: 31351459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid may benefit patients undergoing total hip/knee arthroplasty because of haemophilia.
    Huang ZY; Huang Q; Zeng HJ; Ma J; Shen B; Zhou ZK; Pei FX
    BMC Musculoskelet Disord; 2019 Sep; 20(1):402. PubMed ID: 31481049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.